Mba Advisors LLC Amgen Inc Transaction History

Mba Advisors LLC

$207 Million
Q3 2024

A detailed history of Mba Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Mba Advisors LLC holds 2,852 shares of AMGN stock, worth $754,325. This represents 0.44% of its overall portfolio holdings.

Number of Shares

2,852

Previous 2,892 1.38%

Holding current value

$754,325

Previous $903,000 1.66%

% of portfolio

0.44%

Previous 0.46%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$309.38 - $337.38 $12,375 - $13,495	-40 Reduced 1.38%	2,852 $918,000
Q2 2024 Jul 30, 2024	SELL	$262.75 - $319.31 $6,568 - $7,982	-25 Reduced 0.86%	2,892 $903,000
Q1 2024 Apr 26, 2024	SELL	$268.87 - $324.56 $20,971 - $25,315	-78 Reduced 2.6%	2,917 $829,000
Q4 2023 Jan 19, 2024	SELL	$255.7 - $288.46 $62,390 - $70,384	-244 Reduced 7.53%	2,995 $862,000
Q2 2023 Jul 21, 2023	SELL	$214.27 - $253.37 $19,070 - $22,549	-89 Reduced 2.67%	3,239 $719,000
Q1 2023 Apr 20, 2023	BUY	$225.79 - $275.2 $3,612 - $4,403	16 Added 0.48%	3,328 $804,000
Q4 2022 Jan 25, 2023	BUY	$229.03 - $291.01 $15,803 - $20,079	69 Added 2.13%	3,312 $0
Q3 2022 Oct 31, 2022	BUY	$224.46 - $253.15 $30,751 - $34,681	137 Added 4.41%	3,243 $731,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $219 - $242	-1 Reduced 0.03%	3,106 $751,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $142,994 - $163,644	719 Added 30.11%	3,107 $699,000
Q1 2021 May 18, 2021	BUY	$221.91 - $258.6 $529,921 - $617,536	2,388 New	2,388 $594,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mba Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mba Advisors LLC with notifications on news.

Account